Merck recalls Gardasil vaccine; China probes deaths from hep C vaccine; Pfizer to hire women at Saudi plant;

> Merck ($MRK) is recalling more than 743,000 vials of Gardasil HPV vaccines because of the chance of glass particles in a small number of vials. Story

> China, which has been trying to demonstrate adequate oversight of its growing drug industry, is investigating two of its key vaccine makers after the deaths of 8 children were tied to their hepatitis B vaccines. Story (sub. req.)

> ANI Pharmaceuticals will pay Teva Pharmaceutical Industries ($TEVA) $12.5 million in cash and a percentage of future gross profits in exchange for getting 31 previously marketed generic drug products from the Israeli drugmaker. Release

> New reports suggest Daiichi Sankyo will have a hard time collecting any award from shareholders that the Japanese drugmaker has accused of hiding quality problems at the troubled Ranbaxy Laboratories before Daiichi bought it in 2008. Report

And Finally... Pfizer ($PFE) intends to hire more women at a plant it is building in Saudi Arabia in accordance with new government policies try to extend to women the opportunity to participate more in the country's economic development. Story